High Technology/Health Care Sectors - Biomedical Devices Committee
	Back to High Tech Sector Home
	Back to Health Care Sector Home
Contacts, Mission Statement and Activities

Co-Chair:	Roger Hahn	Email
Co-Chair:	Mark Bloom	Email
Chair-Elect:	Tim Squire	Email

Committee Mission Statement:

• Provide a forum for education, discussion, and networking for LES members interested in the technology transfer and licensing of Biomedical Device-related technologies.
• Foster collaboration within the Biomedical Device industry and between this multidisciplinary industry and related technical fields, e.g., pharmaceuticals, biotechnology, nanotechnology, diagnostics, and imaging, etc.
• Investigate and present issues important to the Biomedical Device industry through LES publications and live content provided at LES meetings.
• Introduce and champion LES and LES membership to the Biomedical Device community.

• Explore the multidisciplinary nature of the Biomedical Device industry with an emphasis on finding specific areas for collaboration and differentiation.
• Investigate the changes and evolution of patenting, licensing, and regulatory/marketing strategies employed in the Biomedical Device industry.
• Examine the impact of public policy issues on the Biomedical Device industry, with particular emphasis on patenting, regulation, and third-party payer initiatives.
• Develop live content programming for the LES Meetings and recruit speakers for these programs.

I. Definitions

Historically, the problem with biomedical/bioengineering has been the inability to establish a clear and comprehensive identity due to its cross-disciplinary nature. There is a vast nexus between basic physical engineering and application of that science to medical and biological systems. The formation of a separate biomedical device committee will bring into focus a clear identity while facilitating workflow and cooperation between the High Technology (HT) and Healthcare (HC) Sectors. As part of that, the committee Co-chairs propose adopting a working definition of "biomedical device/bioengineering" promulgated by the American Institute of Medical Bioengineering (AIMBE): "medical and biological engineering encompasses the fields of clinical medicine, food, agriculture and environmental bioremediation". This definition can be added/modified/changed or adopted according to the committee's suggestions and/or recommendations.

II. Objectives

1. Create a platform to share best practices, current standards, and trends in licensing and IP management for medical and biological engineering;
2. Network between industry-specific contacts and coordinate a constituency of biomedical/bioengineering practitioners;
3. Focus on trends and the future outlook for the biomedical device field;
4. Increase and recruit LES (and Biomedical Device Committee) membership;
5. Outline reimbursement strategies within the industry;
6. Facilitate the chartering of the Joint Biomedical Device Committee; and
7. Introduce the LES Membership to the Joint Biomedical Device Committee through various media.

The Biomedical Device Committee shall be a joint committee of the High Technology (HT) and Healthcare (HC) Sectors. Once the nascent Committee has been existence for the appropriate amount of time, each Sector shall be represented by a Co-Chair, a Co-Chair-Elect, and a Past Co-Chair. All Co-Chairs will endeavor to work cooperatively and efficiently to facilitate the functioning of the Committee.

The respective inaugural HT Sector and HC Sector Co-Chairs are:

Roger C. Hahn, Esq.
Hahn & Voight, PLLC
1012 14th Street, NW
Suite 620
Washington, DC 20005
Voice: (202) 637-0020
Fax: (202) 637-0023
roger.hahn@hvpatentlaw.com

Mark G. Bloom, Esq.
Business Success Strategists, LLC
4032 Abbey Park Way
Raleigh, NC 27612
Voice: (919) 326-8733
Fax: (919) 326-8733
E-mail: mbloom@nc.rr.com

IV. Plan of Action

A. Meetings

The Licensing Executives Society is currently accepting proposals for the upcoming 2007 Spring Meeting and the 2007 Annual Meeting. Any preliminary suggestions for workshops, add-ons, and other types of content and sessions should be submitted promptly to the Co-Chairs.

B. Speakers

The committee is currently speaking to and lining up candidates from different national organizations (BMES, AIMBE, MDMA, AdvaMed, etc.) and governmental bodies (USPTO, FDA, etc.). Any additional volunteers or recommendations should contact the Committee.

C. Status

The committee will be recognized within the LES organizational structure with details to follow.